Literature DB >> 14584905

Potential function for the ROS-generating activity of TRACP.

Jussi M Halleen1, Seija R Räisänen, Sari L Alatalo, H Kalervo Väänänen.   

Abstract

TRACP is an enzyme with unknown biological function. It is expressed primarily in bone-resorbing osteoclasts and activated macrophages. In addition to its phosphatase activity, TRACP is capable of generating reactive oxygen species (ROS). In resorbing osteoclasts, TRACP is localized in transcytotic vesicles transporting bone matrix degradation products from the resorption lacuna to a functional secretory domain in the basolateral membrane. ROS generated by TRACP are capable of destroying organic bone matrix components, suggesting that they may be targeted to further destroy initial matrix degradation products in the transcytotic vesicles. The transcytotic route of osteoclasts is analogous with the antigen presentation route of macrophages transporting endocytosed foreign material into cell surface for presentation to other cells of the immune system. Macrophages overexpressing TRACP have elevated levels of intracellular ROS. In alveolar macrophages, TRACP is colocalized with endocytosed Staphylococcus aureus, a pathogen whose clearance is reduced in TRACP-deficient mice, suggesting that ROS generated by TRACP may be targeted to destroy foreign material in the antigen presentation route of macrophages. These data suggest that the ROS generating activity of TRACP may have an important role both in bone resorption and in the immune defense system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584905     DOI: 10.1359/jbmr.2003.18.10.1908

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

1.  Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.

Authors:  Karin Hollberg; Joakim Nordahl; Kjell Hultenby; Silwa Mengarelli-Widholm; Göran Andersson; Finn P Reinholt
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

2.  Direct observation of multiple protonation states in recombinant human purple acid phosphatase.

Authors:  Enrico G Funhoff; Thyra E de Jongh; Bruce A Averill
Journal:  J Biol Inorg Chem       Date:  2005-09-23       Impact factor: 3.358

Review 3.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

4.  Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells.

Authors:  Jinjiang Fan; Kassim Traore; Wenping Li; Hakima Amri; Hongzhan Huang; Cathy Wu; Haolin Chen; Barry Zirkin; Vassilios Papadopoulos
Journal:  Endocrinology       Date:  2010-05-12       Impact factor: 4.736

5.  Association of Blood Biomarkers of Bone Turnover in HIV-1 Infected Individuals Receiving Anti-Retroviral Therapy (ART).

Authors:  Najib Aziz; Anthony W Butch; Joshua J Quint; Roger Detels
Journal:  J AIDS Clin Res       Date:  2014

Review 6.  Purple acid phosphatases: roles in phosphate utilization and new emerging functions.

Authors:  Jyoti Bhadouria; Jitender Giri
Journal:  Plant Cell Rep       Date:  2021-08-17       Impact factor: 4.570

7.  Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.

Authors:  Hui Xie; Mei Sun; Xiao-Bo Liao; Ling-Qing Yuan; Zhi-Feng Sheng; Ji-Cai Meng; Dan Wang; Zhi-Yong Yu; Lei-Yi Zhang; Hou-De Zhou; Xiang-Hang Luo; Hui Li; Xian-Ping Wu; Qi-You Wei; Si-Yuan Tang; Zhao-Yi Wang; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

8.  The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts.

Authors:  Bas ten Harkel; Ton Schoenmaker; Daisy I Picavet; Noel L Davison; Teun J de Vries; Vincent Everts
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

9.  Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts.

Authors:  Kana Harada; Hiromichi Itoh; Yumi Kawazoe; Shuichi Miyazaki; Kazuya Doi; Takayasu Kubo; Yasumasa Akagawa; Toshikazu Shiba
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

10.  Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.

Authors:  L B Solberg; E Stang; S-H Brorson; G Andersson; F P Reinholt
Journal:  Histochem Cell Biol       Date:  2014-09-09       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.